Chronimed suspends Quick Check shipments:
This article was originally published in Clinica
Executive Summary
Chronimed has suspended all shipments of its Quick Check reagent strip in the US because of unresolved issues with its supplier, Diagnostic Solutions, and the FDA. Chronimed has started negotiations to acquire the manufacturing rights of the strip test from Diagnostic Solutions. The company, based in Minneapolis, Minnesota, must also resolve questions the FDA has about inconsistent strip test results before shipments can resume.